Icodec marketing approval

Danish drugmaker Novo Nordisk has announced that its once-weekly basal insulin icodec, used for the treatment of diabetes in adults, has received a recommendation for marketing authorisation in Europe from the European Medicines Agency’s human medicines committee.

 To find out more, CLICK HERE.


Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags